Granahan Investment Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Granahan Investment Management’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-585,444	Closed	-$6.85M	–	206
2020 Q3	$6.85M	Sell	585,444 -210,805	-26%	-$2.8M	0.23%	93
2020 Q2	$10.4M	Sell	796,249 -18,182	-2%	-$218K	0.37%	75
2020 Q1	$7.54M	Sell	814,431 -348	-0%	-$4.86K	0.41%	65
2019 Q4	$13.5M	Buy	814,779 +2,552	+0.3%	+$41.4K	0.62%	46
2019 Q3	$13.5M	Buy	812,227 +34,263	+4%	+$474K	0.74%	37
2019 Q2	$10.7M	Sell	777,964 -54,200	-7%	-$829K	0.53%	52
2019 Q1	$14.3M	Sell	832,164 -62,965	-7%	-$996K	0.77%	42
2018 Q4	$11.4M	Buy	895,129 +49,746	+6%	+$754K	0.81%	40
2018 Q3	$13.7M	Buy	845,383 +280,051	+50%	+$4M	0.74%	45
2018 Q2	$7.29M	Buy	565,332 +47,159	+9%	+$637K	0.44%	75
2018 Q1	$6.45M	Buy	518,173 +2,896	+0.6%	+$35.3K	0.47%	74
2017 Q4	$7.2M	Buy	515,277 +13,970	+3%	+$205K	0.57%	63
2017 Q3	$8.42M	Buy	501,307 +36,187	+8%	+$589K	0.7%	45
2017 Q2	$7.82M	Buy	465,120 +169,643	+57%	+$2.54M	0.72%	42
2017 Q1	$4.58M	Buy	+295,477	New	+$4.22M	0.46%	79

Other funds holding OXFD

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $432M AUM 42.58% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Granahan Investment Management's OXFD Position: Q4 2020 in Review

Granahan Investment Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q4 2020, closing a stake of 585,444 shares — an estimated $6.85M sold.

Granahan Investment Management first reported a position in OXFD in Q1 2017 and held it in 15 quarters. The position peaked at $14.3M in Q1 2019. 60 funds tracked by Wall St. Rank hold OXFD as of Q4 2020.

Granahan Investment Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q4 2020 after selling out during the quarter.
Granahan Investment Management sold 585,444 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2020, an estimated $6.85M.
Granahan Investment Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2017 and held it in 15 quarters.
Granahan Investment Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $14.3M in Q1 2019.
60 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2020.

Based on Granahan Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.